. . . . . . . . . "\"Risedronate Sodium is contraindicated in patients with the following conditions: Abnormalities of the esophagus which delay esophageal emptying such as stricture or achalasia [ see Warnings and Precautions ( 5.1 ) Inability to stand or sit upright for at least 30 minutes [ see Dosage and Administration ( 2 ), Warnings and Precautions ( 5.1 ) Hypocalcemia [ see Warnings and Precautions ( 5.2 ) Known hypersensitivity to Risedronate Sodium or any of its excipients. Angioedema, generalized rash, bullous skin reactions, Stevens-Johnson syndrome and toxic epidermal necrolysis have been reported [ see Adverse Reactions ( 6.2 ) Abnormalities of the esophagus which delay esophageal emptying such as stricture or achalasia ( 4 5.1 Inability to stand or sit upright for at least 30 minutes ( 4 5.1 Hypocalcemia ( 4 5.2 Known hypersensitivity to any component of this product ( 4 6.2\"" . . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" . "RBTSZHIj9GTmzO1LkWSbnC/RuBS8xeUU7LoOtmxkDkcsO2j5FepvDeRJnSmAoopWmJa1e5EduM1rWhM143unfdvwLWkTY5FwbBKkkqjbNsL+M6D1Cycwkpy15vIoWvU1lid5H9e9/MrEVRTxHtGLmjqeqXxgIJoHRd7CWqVp2Nw=" . . "2021-08-23T13:12:28.811+02:00"^^ . . . . .